Park Dental Partners, Inc. (PARK)

NASDAQ:PARK

PARK

Park Dental Partners, Inc.

RESEARCH TOOLSreports

Want to see PARK full AI Analyst Report?

Park Dental Partners, Inc. (PARK) Earnings Dates, Call Summary & Reports

10 Followers

Earnings Data

Report Date

Mar 03, 2027

After Close (Confirmed)

Period Ending

2026 (Q4)

Consensus EPS Forecast

―

Last Year’s EPS

0.3

Same Quarter Last Year

Analyst Consensus

Moderate Buy

Based on 1 Analysts Ratings

Earnings Call Summary

Q1 2026

Earnings Call Date:May 13, 2026|

% Change Since:

Earnings Call Sentiment|Positive

The call conveyed solid operational momentum with mid-single-digit revenue growth (6.2% YoY), healthy same-practice growth (4.1%), positive adjusted EBITDA and cash flow, a strong patient retention rate (>90%), and a robust M&A pipeline and balance sheet. Near-term GAAP profitability is pressured by elevated share-based compensation (IPO vesting acceleration), higher public company costs, and a larger share count that depresses GAAP EPS versus prior year. Management maintained full-year guidance and emphasized continued investments in capacity and disciplined M&A. Overall, positive operational and liquidity indicators outweigh the near-term GAAP expense headwinds and seasonality risks.

Company Guidance

Park Dental maintained its full‑year 2026 outlook after a Q1 that produced $62.7M of revenue (up 6.2% YoY) with same‑practice revenue growth of 4.1%, general practice revenue of $46.1M (+6.4%) and multi‑specialty revenue of $16.6M (+5.7%); adjusted EBITDA was $4.7M (7.6% margin) and adjusted EPS $0.44, while GAAP showed a net loss of $0.4M (‑$0.09/sh) versus prior‑year Q1 net income of $1.6M ($0.88/sh). The company ended the quarter with $24.4M of cash, $11.5M of total debt, an undrawn $15M revolver, and $5M of operating cash flow; it has 221 doctors across three states and patient retention just over 90%. Management said elevated share‑based compensation (about 91% attributable to doctor shareholders) and public‑company costs are expected post‑IPO but will decline as accelerated vesting is recognized, reiterated that M&A is the primary growth lever (with de novos a smaller driver), plans to enter 2–3 new markets over the next few years, and expects Q2 revenue growth to be lower than Q1 with Q3–Q4 tracking at or above Q1 as seasonal hiring and year‑end/early‑year acquisitions are integrated into the second half.

Revenue Growth

Q1 revenue of $62.7M, representing 6.2% year-over-year growth, driven by organic patient demand and provider base expansion.

Same-Practice Performance

Same-practice revenue growth of 4.1%, supported by increased patient visits, expanded clinical hours, and modest fee/reimbursement growth.

Segment Growth

General practice revenue rose 6.4% to $46.1M; multi-specialty revenue grew 5.7% to $16.6M, reflecting broad-based demand across service lines.

Profitability on a Non-GAAP Basis

Adjusted EBITDA of $4.7M (7.6% of revenue) and adjusted EPS of $0.44 for the quarter, indicating positive underlying operating performance after non-GAAP adjustments.

Strong Patient Metrics and Provider Base

Patient retention just over 90% and an expanding provider base of 221 doctors across three states, enabling capacity growth and long-term revenue potential.

Balance Sheet and Cash Flow

Quarter-end cash of $24.4M, total debt of $11.5M, an undrawn $15M revolver, and operating cash flow of $5M, providing liquidity and flexibility for growth.

M&A Pipeline and Integration

Completed one acquisition in the quarter with a healthy, diversified pipeline (solo to larger groups). Integration example: Arizona practices conversion to common practice management system progressing smoothly.

Recognition and Clinical Leadership

Clinical leadership highlighted by Dr. Alan Law receiving the Edgar D. Coolidge Award from the American Association of Endodontists — a reputational positive for the company.

Park Dental Partners, Inc. (PARK) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

PARK Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 03, 2027	2026 (Q4)	- / -	0.3	―	―	―
May 13, 2026	2026 (Q1)	0.20 / 0.44	―	―	―
Feb 25, 2026	2025 (Q4)	-0.07 / 0.30	―	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

PARK Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 13, 2026	$18.30	$17.98	-1.75%
Feb 25, 2026	$20.32	$19.41	-4.48%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Park Dental Partners, Inc. (PARK) report earnings?

Park Dental Partners, Inc. (PARK) is schdueled to report earning on Mar 03, 2027, After Close (Confirmed).

What is Park Dental Partners, Inc. (PARK) earnings time?

Park Dental Partners, Inc. (PARK) earnings time is at Mar 03, 2027, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is PARK EPS forecast?

Currently, no data Available